AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-248647899/aosaikang-pharma-signs-deal.html" title="Facts and information about Aosaikang Pharma signs deal with New Zealand diabetes company.">Aosaikang Pharma signs deal with New Zealand diabetes company.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Aosaikang Pharma signs deal with New Zealand diabetes company.
Jiangsu Aosaikang Pharmaceutical (Aosaikang Pharma) of Nanjing purchased a 5% stake in a New Zealand pharma, Living Cell Technologies (LCT), for $1.7 M. LCT's major product, Diabecell, is a technology that implants encapsulated …
Related articles from newspapers, magazines, journals, and more
